4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-055856
Chief Scientific Officer sold 2,146 shares at $67.23 ($144,276)
- Chief Scientific Officer acquired 2,146 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Scott · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-10-02 | Exercise or conversion : show line 1 in the form | +1,191 | $9.05 | $10,779 | 7,455 | D |
| 2017-10-02 | Sale : show line 2 in the form | −1,191 | $67.23 | $80,071 | 6,264 | D |
| 2017-10-02 | Exercise or conversion : show line 3 in the form | +955 | $31.64 | $30,216 | 7,219 | D |
| 2017-10-02 | Sale : show line 4 in the form | −955 | $67.23 | $64,205 | 6,264 | D |
| Open-market sales · 2,146 sh · avg $67.23 · $144,276 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-10-02 | Exercise or conversion : show line 5 in the form Stock option (right to buy) | −1,191 | 34,090 | D |
| 2017-10-02 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −955 | 34,331 | D |
Loading xslF345X03/doc4.xml…